Stroke News

CHICAGO — Compared with usual care, a shared decision-making pathway reduced decisional conflict associated with the use of anticoagulation for stroke prevention in atrial fibrillation at 1 month, according to the ENHANCE-AF study.

CHICAGO — A drug derived from traditional Chinese medicine as an adjunct to guideline-directed therapy improved CV outcomes at 30 days and 1 year compared with placebo after revascularization, with no excess bleeding risk, a speaker reported.

CHICAGO — Among older veterans with hypertension, there was no difference in the incidence of major adverse CV events after treatment with hydrochlorothiazide compared with chlorthalidone, according to new research.

Compared with other direct oral anticoagulants, apixaban was associated with lower rates of gastrointestinal bleeding but similar rates of ischemic stroke and all-cause mortality among adults with atrial fibrillation, data show.

After a minor stroke or transient ischemic attack, patients with normal vs. impaired renal function treated with ticagrelor plus aspirin had lower risk for stroke at 90 days compared with clopidogrel plus aspirin, researchers reported.

Patients with rheumatoid arthritis who are on Social Security Disability Insurance have a 23% higher risk for cardiovascular disease compared with those considered employable, according to data published in Arthritis Research & Therapy.

Irregular and long menstrual cycles were associated with elevated risk for incident CVD events, primarily CHD, according to research published in JAMA Network Open.

Regular coffee intake of multiple subtypes was associated with preventing CVD, mortality and incident arrhythmias, according to a study.

In patients who had endovascular thrombectomy for acute ischemic stroke with large-vessel occlusion, intensive systolic BP control to less than 120 mm Hg was linked with poor outcomes after the procedure, researchers reported.

From 2016 to 2019, percutaneous left atrial appendage occlusion procedures for stroke prevention rose and major adverse events associated with them fell, according to a real-world analysis published in HeartRhythm.